Database I: Genetic Tests for Cancer: Database of genetic tests currently available
Return to Contents
1. Test (by type of test)
Name |
Other Names |
Primary Prevention |
Secondary Prevention |
Diagnostic |
Prognostic |
Recurrence |
Monitoring |
Specimen |
Acid phosphatase, total and prostatic |
PAP |
|
|
|
x |
x |
x |
serum |
Adrenocorticotropic hormone |
ACTH |
|
|
x |
|
|
|
plasma |
Alpha fetoprotein |
AFP |
|
x |
|
x |
x |
x |
serum |
AML1/ETO translocation |
t(8;21) |
|
|
x |
x |
x |
x |
blood, marrow |
B-cell gene rearrangement |
|
|
|
x |
x |
x |
|
blood, marrow, tissue |
BCL-1/JH gene rearrangement |
t(11;14) |
|
|
x |
x |
|
x |
blood, marrow, tissue |
BCL-2 translocation |
t(14;18) |
|
|
x |
x |
x |
x |
blood, marrow, tissue |
BCR/ABL gene rearrangement |
Philadelphia chromosome |
|
|
x |
x |
x |
x |
blood, marrow |
Beta human chorionic gonadotropin |
b-HCG |
|
|
x |
|
x |
x |
serum |
Beta-2 microglobulin |
|
|
|
x |
x |
|
|
serum |
Bladder tumor antigen |
BTA |
|
|
|
|
x |
x |
urine |
BRCA Analysis |
BRCA1, BRCA2 |
x |
|
|
x |
|
|
blood |
Calcitonin |
|
|
x |
x |
x |
x |
|
serum |
Cancer antigen 125 |
CA 125 |
|
|
|
|
x |
x |
serum |
Cancer antigen 15-3 |
CA 15-3 |
|
|
|
|
x |
x |
serum |
Cancer antigen 19-9 |
CA 19-9 |
|
|
|
|
x |
x |
serum |
Cancer antigen 27.29 |
CA 27.29 |
|
|
|
|
x |
x |
serum |
Carcinoembryonic antigen |
CEA |
|
x |
|
x |
x |
x |
serum |
Cathepsin D |
|
|
|
|
x |
|
|
tissue |
CBFB/MYH11 fusion protein |
inv(16), t(16;16) |
|
|
x |
x |
|
x |
blood, marrow |
CD 117, c-kit |
Gleevec sensitivity |
|
|
x |
|
|
|
tissue |
CD 20 |
Rituxan sensitivity |
|
|
x |
|
|
|
blood |
CD 25 |
Ontak sensitivity |
|
|
x |
|
|
|
Blood, marrow, tissue |
CD 33 |
Mylotarg sensitivity |
|
|
x |
|
|
|
Blood, marrow |
CD 52 |
Campath sensitivity |
|
|
x |
|
|
|
Blood, marrow |
Chromosome 18q assay |
18q/RER, DCC |
|
|
x |
x |
|
|
Blood, tissue |
Colaris |
MLH1, MSH2 |
|
x |
x |
|
|
|
Blood |
Colaris AP |
APC, FAP |
|
x |
x |
|
|
|
Blood |
Cyclin-D1 |
|
|
|
x |
x |
|
|
Tissue |
E-cadherin |
|
|
|
|
x |
|
|
Tissue |
Epidermal growth factor receptor |
EGFR pharmDx, HER-1, Erbitux sensitivity |
|
|
x |
|
|
|
Tissue |
Estrogen/progesterone receptor |
ER/PR |
|
|
x |
x |
|
|
Tissue |
Fecal globin |
InSure, FOBT |
|
x |
|
|
|
|
Stool |
FLT 3 mutation |
|
|
|
|
x |
|
|
Blood |
HER-2/neu |
c-erbB-2, PathVysion, Herceptin eligibility |
|
|
x |
x |
|
|
Tissue |
5-HIAA |
5-hydroxyindoleacetic acid |
|
|
x |
x |
|
|
Urine |
Human papillomavius hybrid capture |
HPV, ThinPrep |
|
x |
|
|
|
|
Pap smear |
IgVH mutation analysis |
|
|
|
|
x |
|
|
Blood, marrow |
Immunocyt |
mucin, CEA |
|
|
|
|
x |
x |
Urine |
Kappa/lambda light chain |
|
|
|
|
|
|
x |
Blood, tissue |
LAP |
leukocyte alkaline phosphatase |
|
|
x |
|
|
x |
Blood, marrow |
Lipid associated sialic acid |
LASA, LSA |
|
|
|
|
x |
x |
Serum |
Melaris |
p16 |
x |
|
|
|
|
|
Blood |
MIB-1 antibody |
Ki-67 antigen |
|
|
|
x |
|
|
Tissue |
Micrometastasis detection |
cytokeratins |
|
|
|
|
x |
x |
Marrow, tissue |
Microsatellite instability |
MSI, BAT-26, RER+, HNPCC |
x |
x |
x |
x |
|
|
Blood, tissue |
MLH1, MSH2, MSH6 mutations |
HNPCC mismatch repair gene |
x |
|
|
|
|
|
Blood |
Neuron specific enolase |
NSE |
|
|
|
|
|
x |
Serum |
Nuclear matrix proteins |
NMP 22 |
|
|
x |
|
x |
x |
Urine |
Oncotype Dx |
Breast cancer assay |
|
|
|
x |
|
|
Tissue |
p53 tumor suppressor gene |
p53 |
|
|
|
x |
|
|
Tissue |
PML/RARA translocation |
t(15;17) |
|
|
x |
x |
|
x |
Blood, marrow |
PreGen-26 |
MSI, BAT-26 |
x |
x |
|
|
|
x |
Stool |
PreGen-Plus |
k-ras, APC, p53 |
|
x |
|
|
|
x |
Stool |
Prostate-specific antigen |
PSA free, total, ultrasensitive, HAMA |
|
x |
|
x |
x |
x |
Blood |
T-cell recepter gene rearrangment |
|
|
|
x |
|
|
|
Blood, marrow, tissue |
TEL/AML1 gene fusion |
t(12;21) |
|
|
x |
x |
|
x |
Blood, marrow |
Thyroglobulin |
|
|
|
|
|
x |
x |
Serum |
Tumor antigen 90 immune complex |
TA90-IC |
|
|
|
x |
x |
x |
Serum |
Urokinase plasminogen activator |
uPA, PAI-1 (plasminogen activitor inhibitor) |
|
|
|
x |
|
|
Tissue |
Urovysion |
Vysis Urovysion |
|
|
|
|
x |
|
Urine |
ZAP-70 |
|
|
|
|
x |
|
|
Blood, marrow |
Return to Contents
Proceed to Next Section
|